New Mexico Educational Retirement Board Biogen Inc. Transaction History

New Mexico Educational Retirement Board

  • $2.98 Billion
  • Q4 2024

A detailed history of New Mexico Educational Retirement Board transactions in Biogen Inc. stock. As of the latest transaction made, New Mexico Educational Retirement Board holds 6,924 shares of BIIB stock, worth $996,571. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,924
Previous 7,124 2.81%
Holding current value
$996,571
Previous $1.38 Million 23.32%
% of portfolio
0.04%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$146.47 - $191.55 $29,294 - $38,310
-200 Reduced 2.81%
6,924 $1.06 Million
Q3 2024

Nov 12, 2024
SELL
$189.07 - $236.8 $37,814 - $47,360
-200 Reduced 2.73%
7,124 $1.38 Million
Q1 2024

Apr 23, 2024
SELL
$212.02 - $267.71 $254,424 - $321,252
-1,200 Reduced 14.08%
7,324 $1.58 Million
Q1 2024

Apr 17, 2024
BUY
$212.02 - $267.71 $212,020 - $267,710
1,000 Added 13.29%
8,524 $1.8 Million
Q3 2023

Nov 01, 2023
BUY
$253.3 - $285.89 $126,650 - $142,945
500 Added 7.12%
7,524 $1.93 Million
Q2 2023

Jul 17, 2023
BUY
$275.25 - $318.06 $110,100 - $127,224
400 Added 6.04%
7,024 $2 Million
Q1 2023

May 03, 2023
SELL
$256.56 - $292.34 $76,968 - $87,701
-300 Reduced 4.33%
6,624 $1.84 Million
Q4 2022

Feb 01, 2023
SELL
$252.44 - $306.72 $151,464 - $184,032
-600 Reduced 7.97%
6,924 $1.92 Million
Q3 2022

Oct 18, 2022
SELL
$194.69 - $268.46 $116,814 - $161,076
-600 Reduced 7.39%
7,524 $2.01 Million
Q2 2022

Jul 21, 2022
SELL
$187.54 - $223.02 $75,016 - $89,208
-400 Reduced 4.69%
8,124 $1.66 Million
Q1 2022

Apr 01, 2022
SELL
$193.77 - $244.14 $116,262 - $146,484
-600 Reduced 6.58%
8,524 $1.8 Million
Q4 2021

Jan 19, 2022
SELL
$223.92 - $287.77 $156,744 - $201,439
-700 Reduced 7.13%
9,124 $2.19 Million
Q3 2021

Oct 19, 2021
SELL
$282.99 - $369.05 $84,897 - $110,715
-300 Reduced 2.96%
9,824 $2.78 Million
Q2 2021

Jul 13, 2021
BUY
$259.0 - $414.71 $25,900 - $41,471
100 Added 1.0%
10,124 $3.51 Million
Q4 2020

Feb 02, 2021
SELL
$236.26 - $355.63 $94,504 - $142,252
-400 Reduced 3.84%
10,024 $2.45 Million
Q3 2020

Oct 28, 2020
SELL
$264.77 - $305.71 $1.2 Million - $1.39 Million
-4,550 Reduced 30.39%
10,424 $2.96 Million
Q3 2020

Oct 27, 2020
BUY
$264.77 - $305.71 $754,594 - $871,273
2,850 Added 23.51%
14,974 $3.49 Million
Q2 2020

Aug 06, 2020
BUY
$258.66 - $342.55 $206,928 - $274,040
800 Added 7.06%
12,124 $3.24 Million
Q1 2020

Jun 11, 2020
SELL
$268.85 - $341.04 $981,302 - $1.24 Million
-3,650 Reduced 24.38%
11,324 $3.58 Million
Q3 2019

Nov 25, 2019
SELL
$217.44 - $243.88 $239,184 - $268,268
-1,100 Reduced 6.84%
14,974 $3.49 Million
Q2 2019

Aug 06, 2019
SELL
$219.29 - $241.72 $153,503 - $169,204
-700 Reduced 4.17%
16,074 $3.76 Million
Q1 2019

Apr 17, 2019
SELL
$216.71 - $338.96 $86,684 - $135,584
-400 Reduced 2.33%
16,774 $3.97 Million
Q4 2018

Jan 28, 2019
SELL
$278.5 - $352.75 $445,600 - $564,400
-1,600 Reduced 8.52%
17,174 $5.17 Million
Q3 2018

Nov 19, 2018
SELL
$293.51 - $383.83 $205,457 - $268,681
-700 Reduced 3.59%
18,774 $6.63 Million
Q2 2018

Aug 01, 2018
SELL
$257.52 - $306.91 $180,264 - $214,837
-700 Reduced 3.47%
19,474 $5.65 Million
Q1 2018

Apr 25, 2018
SELL
$260.13 - $367.91 $26,013 - $36,791
-100 Reduced 0.49%
20,174 $5.52 Million
Q4 2017

Feb 08, 2018
BUY
$307.64 - $344.58 $123,056 - $137,832
400 Added 2.01%
20,274 $6.46 Million
Q3 2017

Nov 21, 2017
BUY
$281.15 - $329.69 $5.59 Million - $6.55 Million
19,874
19,874 $6.22 Million

Others Institutions Holding BIIB

# of Institutions
998
Shares Held
130M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track New Mexico Educational Retirement Board Portfolio

Follow New Mexico Educational Retirement Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

News

Stay updated on New Mexico Educational Retirement Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email